SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

KalVista Pharmaceuticals Files SEC Form

KalVista Pharmaceuticals submits regulatory filing with the SEC. The filing is available for public review.

KALV

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.